“Biopreservation Market Report is set to have rapid growth due to consistent drug developments, advent of advanced therapies in the field of biomedical research and significant rise in patient base requiring high-end treatment for chronic diseases at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Biopreservation Market Report : By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), By Cell Provider, Regional And Segment Forecasts

The global biopreservation market is poised for rapid growth between 2019 and 2029. The drivers include increasing healthcare expenditure, growing demand for preserving new-born’s stem cells, increasing R&D spending on research, and increasing adoption of regenerative medicine.

An increase in healthcare costs is also expected to improve access to quality health care and advanced products, which include biopreservation facilities, thus expanding growth prospects. In addition, hospitals, gene banks and biobanks, which are significant end users for this market, are encouraging key players to develop technologically advanced biopreservation products to improve patient outcomes.

The presence of government health initiatives that provide funds, grants and research contracts have led to an accelerated growth of research and development activities carried out by various companies. This, in turn, has led to the expansion of the possibility of adopting advanced bioconservation services, which is foreseen for the rate of fuel penetration during the forecast period.

Technological advances in biopreservation processes are also important growth factors that contribute to the market. Advances include the change in the formulation of hypothermic conservation solutions, next-generation cryopreservation solutions and design and integration with nanoscale technologies. These technological updates have led to the conservation and long-term storage of complex organs and tissues of great importance in regenerative medicine and organ transplantation.

Leading companies featured in the report include BioLife Solutions Inc., BioCision, Biomatrica, Chart MVE Biomedical, TissueGene, LabVantage Solutions, Panasonic Biomedical, Qiagen, Taylor-Wharton Cryogenics and Thermo Fisher Scientific

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

Read

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

Read

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

Read

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever